Pricing Log in Create free account

Electra Therapeutics Inc. (ETRA) vs Monopar Therapeutics Inc. (MNPR)

Electra Therapeutics Inc. and Monopar Therapeutics Inc. are both Biotechnology companies. Electra Therapeutics Inc. and Monopar Therapeutics Inc. are of similar size ($506.5M and $469.1M).

Valuation

Metric ETRA MNPR Biotechnology median
P/E — n/m 10.64
P/S — n/m 9.59
P/B — 4.55 2.15
Price to free cash flow — n/m 26.07
EV/EBITDA — n/m 0.65
EV/Sales — n/m 9.45
Earnings yield — (3.11%) (34.69%)
Free cash flow yield — (2.05%) (24.02%)

Profitability

Metric ETRA MNPR Biotechnology median
Gross margin — — 65.59%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin — 0.00% 0.00%
Return on equity — (19.50%) (51.96%)
Return on assets — (18.90%) (46.06%)
Return on invested capital — 0.00% 0.00%

Growth

Metric ETRA MNPR Biotechnology median
Revenue growth (TTM) — — 4.59%
EPS growth (last fiscal year) — 54.99% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ETRA MNPR Biotechnology median
Debt to equity — 0.00 0.00
Current ratio — 33.56 4.86
Net debt to EBITDA — 8.06 1.01

Dividend

Metric ETRA MNPR Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric ETRA MNPR Biotechnology median
Market cap 506.53m 469.11m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack